President - Paul R. Pescatello
A highly effective voice for the life sciences, Mr. Pescatello was a key to the successful advocacy for an array of policies and legislation that have been key to making New England a vibrant location for biopharma research and development. He has been a leader in building a regenerative medicine research infrastructure in New England (including $100 million in funds in Connecticut to support stem cell research), translation of basic research into clinical therapies, and tax and intellectual property policies that nurture the life sciences and the cures and treatments they produce. He works in the legislative and executive branch areas of each of New England's capitols.
Mr. Pescatello is an attorney with over 25 years of experience as an advocate and counsel for banking, investment-related and technology interests. As a partner at the law firm Shipman & Goodwin, Special Counsel to the Governor and as President and CEO of Connecticut United for Research Excellence, Mr. Pescatello was responsible for drafting and lobbying tax and economic development legislation, conceived by Harvard Business School Professor Michael Porter and others, to make Connecticut more hospitable to start-up companies, small businesses and entrepreneurialism. He currently sits on numerous boards, including Connecticut Innovations, Inc., a quasi-public seed and venture capital firm. He also serves on the Regenerative Medicine Research Fund Advisory Committee, Connecticut Department of Public Health’s Umbilical Cord Blood Bank Committee, the Statewide Biobank Feasibility Study Committee and the Healthcare Working Group’s Clinical Trials Supersite Subcommittee.
In addition to his public affairs and public policy activities, Mr. Pescatello represents several privately-held investment partnerships and limited liability companies.
Mr. Pescatello received a J.D. from the University of Virginia School of Law and a Ph.D. from CornellUniversity. He also holds a B.A. in political economy from ColoradoCollege.